Partners
Event Partner:
KinetoChem LLC is a US-based company which manufactures high purity synthetic cannabinoids for all stages of research. We offer Active Pharmaceutical Ingredients (APIs) for pre-clinical, clinical, and consumer goods with various quantities available (milligram, gram, and kilogram). Our facility and manufacturing processes meet all state and federal regulatory requirements including DEA Schedule I licensing for Analysis, Bulk Manufacturing, and Export.
Spotlight Partner:
Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The Company’s operations and research and development activities are based in Israel.
Innocan Pharma’s business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) the research and development of CBD loaded exosomes (“CLX”); (ii) the research and development of the use of CBD loaded liposomes; and (iii) the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products.
Innocan Pharma is led by a multi-disciplinary management and R&D team, headed by:Iris Bincovich, an experienced healthcare Executive, Ron Mayron, former CEO of Teva Israel, one of the largest generic pharmaceutical companies in the world. Yoram Drucker Founder of two Nasdaq traded companies – Pluristem & Brainstorm, working with stem cells, Nir Avram, former member of the pharma innovation team at Perrigo, Prof. Hezy Barenholz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University – Jerusalem and Prof. Daniel Offen, a leading researcher specializing in Neuroscience and Exosome technology, Head of the Department of Human Molecular Genetics and Biochemistry at Tel Aviv University.
Spotlight Partner:
The ICC Group is a well-respected provider of full-service engineering and design-build services, including automation, Smart 3D design, greenfield construction, and capacity expansion for process-driven industrial clients in liquid manufacturing, chemical, pharmaceutical, petrochemical, brewing and distilling, FMCG, and cannabis industries.
Our team has extensive experience and a proven track record implementing smart and successful operational solutions involving engineering and mass production around the world.
ICC has a long history of building its business by working with a deep portfolio of repeat clients that are some of the most respected companies throughout the world.
Spotlight Partner:
Purisys is a leading supplier of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, and pharmaceutical reference materials. Its 17,000-square-foot manufacturing facility and innovation center in Athens, Georgia is staffed by scientists and other professionals who have decades of experience in complex high-barrier custom synthetic chemistry. Purisys’ expertise in specialty and DEA-scheduled products, including cannabinoid and other controlled substances for registered pharmaceutical applications, is complemented by its extensive regulatory filing experience and know-how to produce dozens of APIs across multiple categories and indications. The company offers a fully operational global supply chain and exports to over 30 countries with full international regulatory compliance. Purisys’ CDMO services are designed to support the development of custom APIs for a wide range of clinical and niche commercial applications, linking product development services, analytical support, and manufacturing in an integrated process. Purisys’ thriving reference standards business stocks a catalog of more than 250 commercial reference standards including structural elucidation and comprehensive analytical data. It also offers custom reference standard synthesis services to support customers’ developmental and commercial needs.
To learn more about Purisys’ products and services, visit www.purisys.com
Exhibition Partner:
NJ Laboratories provides expert analytical chemistry & microbiology testing for the pharmaceutical, nutraceutical, dietary supplement, cosmetic, and cannabis/CBD industries. We are an FDA, DEA, registered & inspected, and ISO/IEC 17025:2017 accredited contract laboratory testing to exacting CGMP standards. Our team of scientists build upon our quality legacy, continually developing and validating methods for raw materials and finished products testing – established upon our founding over 80 years ago.
To learn more about Purisys’ products and services, visit www.njlabs.com
Exhibition Partner:
Averix Bio is the first botanical-based cannabinoid research and extraction company in the United States which meets cGMP 21 CFR Part 210 and Part 211 compliance. We will be offering Active Pharmaceutical Ingredient (API) botanical-based CBD Isolate for pre-clinical, clinical, and consumer goods. Located in North Carolina’s Research Triangle region, the company formerly known as Avient Biosciences has a 200,000-square-foot facility on a 36-acre campus that includes pharmaceutical production suites and on-site analytical testing laboratories. Averix Bio ensures consistent quality from seed to shelf, forming the cornerstone of a corporate foundation built on traceability, transparency, and trust. Led by a world-class team with cGMP/pharmaceutical experience, Averix Bio is on a mission to bring healthier cannabinoid-based medical solutions to a global consumer market.
For more information, visit www.averixbio.com
Exhibition Partner:
Emerald Scientific supplies thousands of scientific products for cannabis research, testing, and production. As our industry and research expands, so does our product line. Our Life Sciences Division focuses on developing and providing products specifically formulated for research including cannabinoids, antibodies, antagonists, and more. Since 2012, Emerald Scientific has been 100% dedicated to promoting collaboration, transparency, and the evolution of science in the cannabis and hemp industries. Our product portfolio is available at EmeraldScientific.com.
To learn more about Emerald Scientific's products and services, visit www.emeraldscientific.com
Program Partner:
Kare Chemical Technologies Inc. (Kare) is a chemical and pharmaceutical technology company located in Ontario, Canada. The company is the global leader and specialist in the use of catalysis for the commercial manufacture of cannabinoids. Kare develops and owns novel compositions of matter precursors that can be converted into single component cannabinoids that are isolated in high chemical and chiral purity under mild conditions. Cannabinoid products include CBD, THC, CBDV, THCV, CBDP, THCP, CBN and many more.
To learn more about Kare’s products and services, visit www.karechem.com
Program Partner:
Headquartered in Roxboro, N.C., Open Book Extracts is a cGMP-certified manufacturer of premium cannabinoid products, aiming to be the industry’s true north by delivering premium products, exceptional service, and industry-leading transparency. With control of the entire supply chain, a state-of-the-art extraction campus near North Carolina’s Research Triangle, proprietary refinement and conversion methods backed by a growing IP portfolio, and a team of PhD chemists and seasoned business leaders, OBX is the trusted partner for global brands seeking to enter the marketplace.
To learn more about Open Book Extract's products and services, visit www.openbookextracts.com
Program Partner:
To learn more about Treehouse Bioscience's products and services, visit www.treehousebiosciences.com/
Program Partner:
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years’ industry experience, Catalent has proven expertise in bringing more customers’ products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply.
To learn more about Catalent's products and services, visit www.catalent.com/
Program Partner:
Vantage Hemp Co. combines a world-class facility with a team of experts, producing premium quality hemp extracts with consistency. With a science-based approach, Vantage Hemp creates full spectrum oil, distillate and isolate for use in exceptional CBD products for the marketplace and medical community. Located in Greely, Colorado, Vantage Hemp’s facilities accommodate pharmaceutical production standards and processes through a detailed multi-stage process. Vantage Hemp’s expert team specializes in medical, pharmaceutical and business operations to formulate and execute the unique and data driven approach with precision. Vantage Hemp Co. has CBD extraction down to a science.
To learn more about Vantage Hemp's products and services, visit www.vantagehemp.com/
Brand Partner:
CBDepot is a pioneer in the production of high-quality cannabinoid ingredients. The company, with roots dating to 2014, has been a leader in helping to establish legal and quality standards for cannabinoid ingredients and the formulation of cannabidiol derivatives that have a fast-growing presence in sectors including food, cosmetics, pharmaceuticals, and other health products.
CBDepot’s approach has always been to lead by example. Being it the first-ever submitted Novel food application for the use of isolated CBD in food back in 2016, or the introduction of the world’s first isolated GMP CBD as an API in 2017.
The company’s initial mission was supplying “Legal and Quality CBD” when sourcing ethical and quality isolated CBD was a challenge. CBDepot’s scientific knowledge is based on close links with the Czech Academy of Sciences.
In 2017, the company’s emphasis evolved to “Legal Natural Cannabinoids” because the legality of the extraction of cannabis was an issue. A short time previously, it had added CBG isolate and various remedied extracts and distillates with concentrations of non-psychoactive cannabinoids, ranging from 50 to 80%, and non-detectable THC.
The company recently changed its strapline “Upmarket Cannabinoid Solutions” reflecting its new ability to offer cannabinoid ingredients and substances to various markets such as cosmetics, food, food supplement, e-cig liquid, and pharmaceuticals and Europe-wide recognition as a strong, ethical, and transparent supplier of cannabinoids.
CBDepot has been a leading participant in the development of a fair and responsible regulatory environment for CBD through its work with the European Union, the United Nations Commission on Narcotic Drugs (CND), the World Health Organization (WHO), and the Foundation for Alternative Approaches to Addiction (FAAAT).
To learn more about CBDepot's products and services, visit www.cbdepot.eu
Digital Partner:
Cannabinoid Clinical is a web-based platform to provide evidence-based cannabinoid information to multi-disciplinary audience. Among the education resources is Covering Cannabinoids, a quarterly newsletter written to provide healthcare providers, payers, and policymakers timely information on scientific facts, trends, and regulations to help you make informed decisions. Sign up to receive this newsletter directly by email or read past issues by clicking the link: https://www.cannabinoidclinical.com/covering-cannabinoids
To learn more about Cannabinoid Clinical's products and services, visit www.cannabinoidclinical.com